Ipertrofan

Mepartricin, the active ingredient in Ipertrofan, is an anthelmintic presented as an oral formulation for oral use. It is employed to treat intestinal helminth infections and to alleviate symptoms of chronic prostatitis in adult patients. The product conforms to European Union pharmaceutical standards and is marketed for use in adult populations.

GNH USA supplies Ipertrofan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring quality assurance, regulatory compliance, and reliable logistics for global distribution, and provides comprehensive post‑sale support.

Mepartricin is used to manage parasitic infections and related urological conditions.

Intestinal helminth infections: eliminates nematodes such as Ascaris, hookworm, and pinworm, reducing gastrointestinal symptoms. Chronic prostatitis: alleviates pelvic pain and inflammation associated with non‑bacterial prostatitis. Parasitic gastrointestinal disorders: controls worm burden in mixed infections, supporting overall gut health.

Mepartricin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate feeling of sickness. - Abdominal discomfort: cramps or pain in the stomach area. - Diarrhea: loose stools occurring after dosing.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): difficulty breathing, swelling, rash. - Hepatotoxicity: marked increase in liver enzymes, jaundice. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Before prescribing Mepartricin, consider the following precautions to ensure safe use. - Pregnancy: use only if potential benefit justifies the risk; data are limited. - Breastfeeding: caution advised as drug may be excreted in milk. - Liver impairment: assess hepatic function and monitor enzymes during therapy. - Renal impairment: adjust dosage if severe renal dysfunction is present. - Drug interactions: review concomitant medications for potential additive toxicity. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture and light.

Mepartricin can interact with other medicines; awareness of major and moderate interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Co‑administration with other anthelmintics: may increase neurotoxicity. - Strong CYP450 inducers (e.g., rifampicin): may reduce Mepartricin plasma levels. - Anticholinergic agents: can exacerbate gastrointestinal side effects.

Moderate Interactions (Monitor Closely): - Antibiotics altering gut flora (e.g., broad‑spectrum penicillins): may affect parasite load and drug efficacy. - Antifungal azoles (e.g., ketoconazole): potential to modify metabolism. - NSAIDs: increased risk of gastrointestinal irritation.